Pandemic influenza A/H1N1 virus infection and TNF, LTA, IL1B, IL6, IL8, and CCL polymorphisms in Mexican population: A case-control study

BMC Infectious Diseases

Volumn 12, Issue , 2012, Pages

  Morales García, Guadalupe ^a   Falfán Valencia, Ramcés ^b   García Ramírez, Román A ^a   Camarena, Ángel ^b   Ramirez Venegas, Alejandra ^b   Castillejos López, Manuel ^b   Pérez Rodríguez, Martha ^a   González Bonilla, César ^a   Grajales Muñíz, Concepción ^a   Borja Aburto, Víctor ^a   Mejía Aranguré, Juan M ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

Author keywords

CCL1; IL1B; IL6; IL8; Influenza AH1N1; LTA; TNF

Indexed keywords

CCL1 CHEMOKINE; CREATINE KINASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LYMPHOTOXIN; OSELTAMIVIR; TUMOR NECROSIS FACTOR;

2009 H1N1 INFLUENZA; ADULT; AGED; ARTICLE; ASTHMA; CASE CONTROL STUDY; CCL GENE; COMORBIDITY; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DISEASE SEVERITY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HYPERTENSION; IL1B GENE; IL6 GENE; IL8 GENE; LTA GENE; MAJOR CLINICAL STUDY; MALE; MEXICO; NEOPLASM; NEUROLOGIC DISEASE; POPULATION RESEARCH; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SYMPTOMATOLOGY; TNF GENE; UREA NITROGEN BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MEXICO; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84871811645     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-299     Document Type: Article

References (35)

1. Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, Uyeki TM, Zaki SR, Hayden FG, Hui DS, Kettner JD, Kumar A, Lim M, Shindo N, Penn C, Nicholson KG. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 2010, 362:1708-1719.
2. Singanayagam A, Singanayagam A, Wood V, Chalmers JD. Factors associated with severe illness in pandemic 2009 influenza A (H1N1) infection: implications for triage in primary and secondary care. J Infect 2011, 63:243-251. 10.1016/j.jinf.2011.07.014, 21839111.
3. Chowell G, Echeverría-Zuno S, Viboud C, Simonsen L, Tamerious J, Miller MA, Borja-Aburto VH. Characterizing the epidemiology of the 2009 influenza A/H1N1 pandemic in Mexico. PLoS Med 2011, 8:e1000436. 10.1371/journal.pmed.1000436, 3101203, 21629683.
4. Ward KA, Spokes PJ, McAnulty JM. Case-control study of risk factors for hospitalization caused by pandemic (H1N1) 2009. Emerg Infect Dis 2011, 17:1409-1416. 3381572, 21801617.
5. Fezeu L, Julia C, Henegar A, Bitu J, Hu FB, Grobbee DE, Kengne AP, Hercberg S, Czernichow S. Obesity is associated with higher risk of intensive care unit admission and death in influenza A (H1N1) patients: a systematic review and meta-analysis. Obes Rev 2011, 12:653-659. 10.1111/j.1467-789X.2011.00864.x, 21457180.
6. Yu H, Feng Z, Uyeki TM, Liao Q, Zhou L, Feng L, Ye M, Xiang N, Huai Y, Yuan Y, Jiang H, Zheng Y, Gargiullo P, Peng Z, Feng Y, Zheng J, Xu C, Zhang Y, Shu Y, Gao Z, Yang W, Wang Y. Risk factors for severe illness with 2009 pandemic influenza A (H1N1) virus infection in China. Clin Infect Dis 2011, 52:457-465. 10.1093/cid/ciq144, 3060897, 21220768.
7. Reyes S, Montulla B, Martínez R, Córdoba J, Molina JM, Martí V, Martínez A, Ramírez P, Menéndez R. Risk factors of H1N1 etiology in pneumonia and impact on mortality. Respir Med 2011, 105:1404-1411. 10.1016/j.rmed.2011.04.011, 21561754.
8. Wen Y, Deng BC, Zhou Y, Wang Y, Cui W, Wang W, Liu P. Immunological features in patients with pneumonitis due to influenza A H1N1 infection. J Investig Allergol Clin Immunol 2011, 21:44-50.
9. To KK, Hung IF, Li IW, Lee KL, Koo CK, Yan WW, Liu R, Ho KY, Chu KH, Watt CL, Luk WK, Lai KY, Chow FL, Mok T, Buckley T, Chan JF, Wong SS, Zheng B, Chen H, Lau CC, Tse H, Cheng VC, Chan KH, Yuen KY. Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis 2010, 50:850-859. 10.1086/650581, 20136415.
10. Bermejo-Martin JF, de Lejarazu RO, Pumarola T, Rello J, Almansa R, Ramirez P, Martin-Loeches I, Varillas D, Gallegos MC, Serón C, Micheloud D, Gomez JM, Tenorio-Abreu A, Ramos MJ, Molina ML, Huidobro S, Sanchez E, Gordón M, Fernández V, Del Castillo A, Marcos MA, Villanueva B, López CJ, Rodríguez-Domínguez M, Galan JC, Cantón R, Lietor A, Rojo S, Eiros JM, Hinojosa C. Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. Crit Care 2009, 13:R201. 10.1186/cc8208, 2811892, 20003352.
11. Michaelis M, Doerr HW, Cinatl J. Of chickens and men: avian influenza in humans. Curr Mol Med 2009, 9:131-151. 10.2174/156652409787581565, 19275623.
12. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, Hoang DM, Chau NV, Khanh TH, Dong VC, Qui PT, Cam BV, Ha DQ, Guan Y, Peiris JS, Chinh NT, Hien TT, Farrar J. Fatal outcome of human influenza A (H5N1) is associated with high viral load of human influenza A. Nat Med 2006, 12:1203-1207. 10.1038/nm1477, 16964257.
13. Mainers TR, Szretter KJ, Perrone L, Belser JA, Bright RA, Zeng H, Tumpey TM, Katz JM. Pathogenesis of emerging avian influenza viruses in mammals and the host innate immune response. Immunol Rev 2008, 225:68-84. 10.1111/j.1600-065X.2008.00690.x, 18837776.
14. Hagau N, Slavcovici A, Gonganau DN, Oltean S, Dirzu DS, Brezoszki ES, Maxim M, Ciuce C, Mlesnite M, Gavrus RL, Laslo C, Hagau R, Petrescu M, Studnicska DM. Clinical aspects and cytokine response in severe H1N1 influenza A virus infection. Crit Care 2010, 14:R203. 10.1186/cc9324, 3220006, 21062445.
15. Wang B, Wang J, Zheng Y, Zhou S, Zhen J, Wang F, Ma X, Zeng Z, . HBV Study Consortium TNF-alpha-238 and -308 polymorphisms with different outcomes of persistent hepatitis B virus infection in china. Pathology 2010, 42:674-680. 10.3109/00313025.2010.523696, 21080879, HBV Study Consortium.
16. Alssani B, Ogwaro KM, Shrestha S, Tang J, Breen EC, Wong HL, Jacobson LP, Rabkin CS, Ambinder RF, Martinez-Maza O, Kaslow RA. The major histocompatibility complex conserved extended haplotype 8.1 in AIDS-related non-Hodgkin lymphoma. J Acquir Immune Defic Syndr 2009, 52:170-179. 10.1097/QAI.0b013e3181b017d5, 3015185, 19654554.
17. Gaudet MM, Egan KM, Lissowska J, Newcomb PA, Brinton LA, Titus-Ernstoff L, Yeager M, Chanock S, Welch R, Peplonska B, Trentham-Dietz A, Garcia-Closas M. Genetic variation in tumor factor and lymphotoxin-alpha (TNA-LTA) and breast cancer risk. Human Genet 2007, 121:483-490.
18. Partida-Rodriguez O, Torres J, Flores-Luna L, Camorlinga M, Nieves-Ramirez M, Lazcano E, Perez-Rodriguez M. Polymorphism in TNF and HSP-70 show a significant association with gastric cancer and duodenal ulcer. Int J Cancer 2010, 126:1861-1868.
19. Ned RM, Yesupriya A, Imperatore G, Smelser D, Moonesinghe R, Chang MH, Dowling NF. nflammation gene variants and susceptibility to albuminuria in U.S. population: analysis in the Third National Health and Nutrition Examination Survey (NHANES III), 1991-94. BMC Med Genet 2010, 11:155. 10.1186/1471-2350-11-155, 2991302, 21054877.
20. Martinez-Carrillo DN, Garza-Gonzalez E, Betancout-Linares R, Mónico-Manzano T, Antúnez-Rivera C, Roman-Roman A, Flores-Alfaro E, Illades-Aguiar B, Fernández-Tilapa G. Association of ILB -511C/-31T haplotypes and Helicobacter Pylori VacA genotypes with gastric ulcer and chronic gastritis. BMC Gastroenterol 2010, 10:126. 10.1186/1471-230X-10-126, 2988070, 20979650.
21. Vazarova B, Fernádez-Real JM, Knoweler WC, Gallart L, Hanson RL, Guber JD, Ricart W, Vendrell J, Richart C, Tataranni PA, Wolford JK. The interleukin-6 (-174) G/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and Caucasians. Hum Genet 2003, 112:409-413.
22. Qi L, Zhang C, van Dam RM, Hu FB. Interleukin-6 genetic variability and adiposity: association in two prospective cohorts and systematic review in 26,944 individuals. J Clin Endocrinol Metab 2007, 92:3618-3625. 10.1210/jc.2007-0877, 17623760.
23. Cheng CH, Lee YS, Tsau YK, Lin TY. Genetic polymorphisms and susceptibility to parenchymal renal infection among pediatric patients. Pediatr Infect Dis J 2011, 30:309-314. 10.1097/INF.0b013e3181ff84ff, 21042230.
24. Heinzmann A, Ahlert I, Kurtz T, Berner R, Deichmann KA. Association study suggests opposite effects of polymorphism within IL8 on bronchial asthma and respiratory syncytial virus bronchiolitis. J Allergy Clin Immunol 2004, 114:671-676. 10.1016/j.jaci.2004.06.038, 15356575.
25. Hacking D, Knight JC, Rockett K, Brown H, Frampton J, Kwiatkowski DP, Hull J, Udalova IA. Increased in vivo transcription of an IL-8 haplotype associated with respiratory syncytial virus disease-susceptibility. Genes Immun 2004, 5:274-282. 10.1038/sj.gene.6364067, 15085176.
26. Hull J, Thomson A, Kwiatkowski D. Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax 2000, 55:1023-1027. 10.1136/thorax.55.12.1023, 1745668, 11083887.
27. Takabatake N, Shibata Y, Abe S, Wada T, Machiva J, Igarashi A, Tokairin Y, Ji G, Sato H, Sata M, Takeishi Y, Emi M, Muramatsu M, Kubota I. A single nucleotide polymorphism in the CCL1 gene predicts acute exacerbations in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006, 174:875-885. 10.1164/rccm.200603-443OC, 16864713.
28. Camarena A, Juárez AM, Estrada A, Carrillo G, Falfán R, Zuñiga J, Navarro C, Granados J, Selman M. Major histocompatibility complex and tumor necrosis factor-α polymorphisms in pigeon breeder's disease. Am J Respir Crit Care Med 2001, 163:1528-1533.
29. Nieves ME, Partida O, Alegre P, Tapia MC, Pérez M. Characterization of single-nucleotide polymorphisms in the tumor necrosis factor α promoter region and lymphotoxin α in squamous intraepithelial lesion, precursors of cervical cancer. Transl Oncol 2011, 4:336-344. 3243656, 22190997.
30. Paskullin DD, Fallavena P, Paludo F, Borges T, Picanco J, Dias F, Alho C. TNF -308G > a promoter polymorphism (rs1800626) and outcome from critical illness. Braz J Infec Dis 2011, 15:231-238.
31. Echevarría-Zuno S, Mejía-Aranguré JM, Mar-Obeso AJ, Grajales-Muñiz C, Robles-Pérez E, González-León M, Ortega-Alvarez MC, Gonzalez-Bonilla C, Rascón-Pacheco RA, Borja-Aburto VH. Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis. Lancet 2009, 374:2072-2079. 10.1016/S0140-6736(09)61638-X, 19913290.
32. WHO information for laboratory diagnosis of pandemic (H1N1) 2009 virus in humans-update 2009, http://www.who.int/csr/resources/publications/swineflu/WHO_Diagnostic_RecommendationsH1N1_20090521.pdf (accessed May 26, 2009).
33. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, Liu F, Dong L, DeVos JR, Gargiullo PM, Brammer TL, Cox NJ, Tumpey TM, Katz JM. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009, 361:1945-1952. 10.1056/NEJMoa0906453, 19745214.
34. Baguelin M, Hoschler K, Stanford E, Waight P, Hardelid P, Andrews N, Miller E. Age-specific incidence of A/H1N1 2009 influenza infection in England from sequential antibody prevalence data using likelihood-based estimation. PLoS One 2011, 6:e17074. 10.1371/journal.pone.0017074, 3044152, 21373639.
35. Papenburg J, Baz M, Hamelin M, Rhéaume C, Carbonneau J, Ouakki M, Rouleau I, Hardy I, Skowronski D, Roger M, Charest H, De Serres G, Boivin G. Household transmission of the 2009 pandemic A/H1N1 influenza virus: elevated laboratory-confirmed secondary attack rates and evidence of asymptomatic infections. Clin Infect Dis 2010, 51:1033-1041. 10.1086/656582, 20887206.